Interview: Christian L Macher, General Manager, AstraZeneca Taiwan
You have been in Taiwan now for ten months. What are the most important characteristics of this market from your perspective, and what surprised you most about Taiwan? Taiwan is…
AstraZeneca Taiwan has a forward vision and the latest innovations as benchmarks; led by General Manager Christian Macher, it has developed a most professional and efficient pharmaceutical team. The company features and promotes a strong business culture by devoting itself to its core competences and unique advantage. It regards people as the core value of the organization and works at creating a ‘Happy at Work’ environment. This environment can develop people’s potentials and enable the company to be ‘The Best’ pharmaceutical company in Taiwan.
AstraZeneca is one of the world’s leading pharmaceutical companies. Backed by a strong research base and extensive manufacturing and commercial skills, the company provides a powerful range of products for seven important areas of healthcare – Gastrointestinal, Cardiovascular, Cancer, Respiratory, Central Nervous System, Pain Control and Infection.
21st Fl., 207, Tun Hwa South RD., Sec.2 Taipei Metro Building, Taipei 106, Taiwan
Telephone：(02)2378-3374
Fax：(02)2377-0913
Website：www.astrazeneca.com.tw
You have been in Taiwan now for ten months. What are the most important characteristics of this market from your perspective, and what surprised you most about Taiwan? Taiwan is…
Tse Wen Chang, internationally recognized as one of the greatest contributors to the biotech field, and founder, CEO, and president of Immunwork, provides insights into the company’s ground-breaking T-E™ pharmaceuticals,…
Ten years after its creation in 2005, InnoPharmax was ranked seventh fastest growing technology company in Taiwan in Deloitte’s “Technology Fast 500 Asia Pacific” annual ranking. CS Hsu, founder and…
Guo-Liang Yu, executive chairman of Crown Bioscience International, on the innovation-driven approach he has instilled since joining in 2013 and how this unique technology platform company now stands as the…
Chuan-Der Huang, founder, president, and CEO of KriSan Biotech, a recently established Taiwan-based service provider focused on new drug process and analytical R&D for small molecules and peptides from Pre-clinical…
Vivian Lee, president and CEO of Linical Taiwan, documents the affiliate’s main milestones since its establishment in 2013, its strategic positioning among the Linical Group as a regional hub, as…
Terry Lin, general manager, and Freia Wei, director for international business at UniPharma, on the company’s move from specialty distribution to drug development and diagnostic products. With an upcoming IPO,…
Yita Lee & Muh-Hwan Su of Sinphar Group & SynCore Bio describe the exciting R&D projects of SynCore Bio, the oncology & dry AMD focused innovation-driven company of the group,…
Jonas Wang Ph.D., Chairman and CEO of StemCyte, a global leader in Regenerative Therapy field including cell processing and transplantation located in the US, Taiwan, and India, provides us with…
In an exclusive interview conducted on the 22nd of December 2016, Taiwan’s Minister of Health and Welfare Lin Tzou-yien discussed improving Taiwan’s National Health Insurance (NHI), ensuring that Taiwanese patients…
The co-founder and president of Mycenax Biotech, Dr. Karen Wen details the key lessons learned from the development of their first in-house product TuNEX® and how they have been applied…
Howard Lee, chairman and CEO of Easywell Biomedicals, documents the most exciting R&D projects that will drive the company to new heights; spanning from a life-changing Parkinson’s transdermal patch to…
Chih-Kung Lee, Minister of Economic Affairs of the Republic of China (Taiwan) provides insights into Taiwan’s “new economic model” recently established by the new government to boost the country’s economic…
See our Cookie Privacy Policy Here
